699855P

3D-(6-acyl) PHAD^™

Avanti Research^™ - A Croda Brand

• 別名: Monophosphoryl Hexa-acyl Lipid A, 3-Deacyl (Synthetic)
• 実験式（ヒル表記法）: C₉₆H₁₈₄N₃O₂₁P
• CAS番号: 252042-59-4
• 分子量: 1747.47
• UNSPSCコード: 12352211
• NACRES: NA.25

特性

• アッセイ: >99% (HPLC)
• フォーム: powder
• 包装: pkg of 1 × 1 mg (699855P-1mg); pkg of 1 × 10 mg (699855P-10MG); pkg of 1 × 10 mg (699855P-25MG); pkg of 1 × 5 mg (699855P-5mg)
• メーカー／製品名: Avanti Research^™ - A Croda Brand
• アプリケーション: vaccine development
• 輸送温度: dry ice
• 保管温度: −20°C
• SMILES記法: O[C@H]([C@@H](CO[C@@H]([C@@H]1NC(C[C@H](OC(CCCCCCCCCCCCC)=O)CCCCCCCCCCC)=O)O[C@H](CO)[C@@H](OP([O-])(O)=O)[C@@H]1OC(C[C@H](OC(CCCCCCCCCCCCC)=O)CCCCCCCCCCC)=O)O[C@H](O)[C@@H]2NC(C[C@H](OC(CCCCCCCCCCCCC)=O)CCCCCCCCCCC)=O)[C@@H]2O.[NH4+]
• InChI: 1S/C96H181N2O21P.H3N/c1-7-13-19-25-31-37-40-46-52-58-64-70-85(102)113-78(67-61-55-49-43-34-28-22-16-10-4)73-83(100)97-89-92(107)91(106)82(116-95(89)108)77-112-96-90(98-84(101)74-79(68-62-56-50-44-35-29-23-17-11-5)114-86(103)71-65-59-53-47-41-38-32-26-20-1
• InChI Key: BKGJOWVNLQLVQX-ZLHZNJIMSA-N

詳細

詳細

Vaccination is well-accepted as an effective method to prevent infections by mounting pathogen-specific immune responses prior to the infection. Usually, immunization with vaccine antigens alone is not able to induce robust or long-lasting immune responses — resulting in failure of protective immunity against infections. Thus, adjuvants are required to enhance cellular or humoral immune responses upon immunization. Because vaccine adjuvants using Lipid A have proven to be safe and effective in inducing Th-1 type immune responses to heterologous proteins in animal and human vaccines, Avanti developed Phosphorylated HexaAcyl Disaccharide (PHAD^™), the first fully synthetic monophosphoryl Lipid A available for use as an adjuvant in human vaccines.

アプリケーション

3D-(6-acyl) PHAD^™ has been used:

• as a synthetic adjuvant in human papillomavirus (HPV) and virus-like particles (VLPs)-based HPV vaccine preparations[1]
• as a component of liposomes for immunizing mice with P. falciparum (Pfs25) malaria transmission-blocking vaccine antigen candidate[2]
• in liposome preparation for the generation of army liposome formulation (ALF) for human immunodeficiency (HIV) gp140 antigen immunization studies in mice[3]

包装

2 mL Amber Glass Crimp Cap Vial (699855P-1mg)

2 mL Amber Glass Crimp Cap Vial (699855P-5mg)

5 mL Amber Glass Screw Cap Vial (699855P-10MG);5 mL Amber Glass Screw Cap Vial (699855P-25MG)

その他情報

For R&D use only. Not for drug, household, or other uses.

法的情報

Avanti Research is a trademark of Avanti Polar Lipids, LLC

PHAD is a trademark of Avanti Polar Lipids, LLC

安全性情報

• 保管分類コード: 11 - Combustible Solids
• WGK: WGK 3
• 引火点(°F): No data available
• 引火点(℃): No data available